Expansion of Vα24+Vβ11+ NKT cells from cord blood mononuclear cells using IL-15, IL-7 and Ft3-L depends on monocytes

European Journal of Immunology

Volumn 36, Issue 1, 2006, Pages 236-244

  Okada, Hikaru ^a,b   Nagamura Inoue, Tokiko ^a   Mori, Yuka ^a   Takahashi, Tsuneo A ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

galactosylceramide; Cord blood; Expansion; Human; V 24+V 11+ NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; FLT3 LIGAND; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 7; ALPHA-GALACTOSYLCERAMIDE; CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; GALACTOSYLCERAMIDE;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD; CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION;

CELL CULTURE TECHNIQUES; FETAL BLOOD; FLOW CYTOMETRY; FMS-LIKE TYROSINE KINASE 3; GALACTOSYLCERAMIDES; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-15; INTERLEUKIN-7; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS;

EID: 30944434020     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526085     Document Type: Article

References (42)

1. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: Facts, functions and fallacies. Immunol. Today 2000. 21: 573-583.
2. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
3. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H. et al., CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
4. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y. et al., Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
5. Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y. et al., Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res. 1999. 59: 5102-5105.
6. Metelitsa, L. S., Naidenko, O. V., Kant, A., Wu, H. W., Loza, M. J., Perussia, B., Kronenberg, M., Seeger, R. C., Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 2001. 167: 3114-3122.
7. Smyth, M. J., Thia, K. Y., Street S. E., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T. et al., Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 2000. 191: 661-668.
8. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 1997. 46: 572-582.
9. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
10. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature 2001. 413: 531-534.
11. Seino, K. I., Fukao, K., Muramoto, K., Yanagisawa, K., Takada, Y., Kakuta, S., Iwakura, Y. et al., Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 2001. 98: 2577-2581.
12. Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002. 195: 637-641.
13. - T cells. J. Exp. Med. 1997. 186: 109-120.
14. Nieda, M., Nicol, A., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H. et al., Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum. Immunol. 1999. 60: 10-19.
15. + NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 2000. 164: 4458-4464.
16. Lin, H., Nieda, M. and Nicol, A. J., Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. Eur. J. Immunol. 2004. 34: 2664-2671.
17. + T cells in vitro. Hum. Immunol. 2000. 61: 357-365.
18. van der Vliet, H. J., Nishi, N., Koezuka, Y., von Blomberg, B. M., van den Eertwegh, A. J., Porcelli, S. A., Pinedo, H. M. et al., Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL 7 and IL-15. J. Immunol. Methods 2001. 247: 61-72.
19. + NKT cells by repeated stimulation with KRN7000. J. Immunol. Methods 2004. 285: 197-214.
20. Kadowaki, N., Antonenko, S., Ho, S., Rissoan, M. C., Soumelis, V., Porcelli, S. A., Lanier, L. L. and Liu, Y. J., Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 2001. 193: 1221-1226.
21. + cells. Br. J. Haematol 2003. 121: 148-156.
22. Ueda, Y., Hagihara, M., Gansuvd, B., Yu, Y., Masui, A., Okamoto, A., Higuchi, A. et al., The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord blood. Cancer Immunol. Immunother. 2003. 52: 625-631.
23. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., De Coene, C., Selz, F., Le Deist, F. and Fischer, A., Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood 1996. 88: 3901-3909.
24. Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N. et al., Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000. 191: 771-780.
25. Lodolce, J. P., Burkett, P. R., Boone, D. L., Chien, M. and Ma, A., T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J. Exp. Med. 2001. 194: 1187-1194.
26. Rathmell, J. C., Farkash, E. A., Gao, W. and Thompson, C. B., IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 2001. 167: 6869-6876.
27. Nakamura-Inoue, T., Mori, Y., Yezhou, Y., Watanabe, N. and Takahashi, T., Differential expansion of umbilical cord blood mononuclear cell derived natural killer cells dependent on the dose of interleukin 15 with Flt3L. Exp. Haematol. 2004. 32: 202-209.
28. Rocha, V., Sanz, G. and Gluckman, E., Umbilical cord blood transplantation. Curr. Opin. Hematol. 2004. 11: 375-385.
29. Rocha, V., Cornish, J., Sievers, E. L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M. et al., Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001. 97: 2962-2971.
30. Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Rosi, A., Jacobsen, N. et al., Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 2004. 351: 2276-2285.
31. Takahashi, S., Iseki, T., Ooi, J., Tomonari, A., Takasugi, K., Shimoha-kamada, Y., Yamada, T. et al., Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004. 104: 3813-3820.
32. Hashimoto, D., Asakura, S., Miyake, S., Yamamura, T., Van Kaer, L., Liu, C., Tanimoto, M. and Teshima, T., Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J. Immunol. 2005. 174: 551-556.
33. Fujii, S., Application of natural killer T-cells to posttransplantation immunotherapy. Int. J. Hematol. 2005. 81: 1-5.
34. Saikh, K. U., Khan, A. S., Kissner, T. and Ulrich, R. G., IL-15-induced conversion of monocytes to mature dendritic cells. Clin. Exp. Immunol. 2001. 126: 447-455.
35. Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., Davoust, J., Bridges, G. et al., Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 2001. 194: 1013-1020.
36. Hammond, K. J., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J. et al., NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 1999. 29: 3768-3781.
37. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. and Bendelac, A., In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 2000. 191: 1895-1903.
38. MacDonald, H. R., Development and selection of NKT cells. Curr. Opin. Immunol. 2002. 14: 250-254.
39. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625-636.
40. + T cells. J. Immunol. 1999. 162: 7067-7074.
41. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H. and Godfrey, D. I., NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 2002. 14: 165-171.
42. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S. et al., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002. 295: 2097-2100.